Search results
32% rise in budget outlay for healthcare in Odisha | Bhubaneswar News - Times of India
The Times of India· 1 day agoBhubaneswar: State govt has allocated Rs 21,200 crore in the budget for public healthcare, an...
Senior citizens want Budget 2024 to hike basic exemption limit to Rs 10 lakh
CNBC Awaaz· 5 days agoThis is in light of the electoral setback that the incumbent Bharatiya Janata Party (BJP) suffered...
Budget 2024 a huge disappointment for health sector: Experts - ET HealthWorld
The Economic Times· 1 day agoNew Delhi: The Finance Minister Nirmala Sitharaman, who presented her seventh consecutive Union...
Cheaper cancer meds and more: How Union Budget 2024 is a shot in the arm to the health sector
Firstpost· 5 days agoUnion Finance Minister Nirmala Sitharaman presented her seventh consecutive Union Budget on Tuesday,...
Budget 2024 key announcements for common man: Will aam aadmi get the much-needed relief from...
The Economic Times· 5 days agoUnion Finance Minister Nirmala Sitharaman is set to present her 7th straight Union Budget today,...
Budget 2024: National Health Mission budget boosted to ₹ 36,000 crore for FY25 - CNBC TV18
CNBC TV18· 5 days agoThe budget for the National Health Mission saw a rise in allocation, increasing from ₹ 31,550.87...
Odisha govt presents Rs 2.65 trn budget for FY25, renames several schemes
Business Standard India· 2 days agoThe BJP government in Odisha presented its maiden budget on Thursday with a total estimate of Rs...
Budget 2024: Doctors welcome decision to exempt 3 cancer drugs from customs duty
Hindustan Times· 5 days agoUnion finance minister Nirmala Sitharaman made the announcement while presenting the Union Budget...
Budget 2024: The approach needed around infrastructure, health, and renewable energy
The Economic Times· 6 days agoBy addressing the critical needs of sectors such as renewable energy, infrastructure, health, and...
Med in India: Quality, affordability, access
The Economic Times· 2 days agoIn her budget speech, Nirmala Sitharaman announced the exemption of trastuzumab deruxtecan, osimertinib and durvalumab, three targeted immunotherapy...